4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-004318
Chief Scientific Officer sold 26,310 shares at an average $19.16 ($504,057)
- Chief Scientific Officer acquired 26,310 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Zago Wagner M. · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-12 | Exercise or conversion : show line 1 in the form | +7,560 | $6.41 | $48,460 | 7,560 | D |
| 2021-02-12 | Sale : show line 2 in the form | −7,560 | $17.07 | $129,049 | 0 | D |
| 2021-02-12 | Exercise or conversion : show line 3 in the form | +18,750 | $13.53 | $253,688 | 18,750 | D |
| 2021-02-12 | Sale : show line 4 in the form | −18,750 | $20.00 | $375,008 | 0 | D |
| Open-market sales · 26,310 sh · avg $19.16 · $504,057 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-12 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −7,560 | $6.41 | 2023-01-29 | 7,560 | 7,540 | D |
| 2021-02-12 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −18,750 | $13.53 | 2029-02-27 | 18,750 | 31,250 | D |
Loading xslF345X03/doc1.xml…